SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-20-002897
Filing Date
2020-11-20
Accepted
2020-11-19 21:44:13
Documents
97

Document Format Files

Seq Description Document Type Size
1 FORM S-1 lxrp_s1.htm S-1 1575979
2 EX-10.31 lxrp_ex1031.htm EX-10.31 459340
3 EX-23.1 lxrp_ex231.htm EX-23.1 3208
10 lxrp_10kimg45.jpg GRAPHIC 1592
11 lxrp_s1img1.jpg GRAPHIC 4790
12 lxrp_s1img2.jpg GRAPHIC 25055
13 lxrp_ex231img4.jpg GRAPHIC 8052
14 lxrp_ex231img5.jpg GRAPHIC 8490
  Complete submission text file 0001640334-20-002897.txt   7610390

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lxrp-20200831.xml EX-101.INS 1419053
5 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20200831.xsd EX-101.SCH 97026
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20200831_cal.xml EX-101.CAL 45433
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20200831_def.xml EX-101.DEF 203145
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20200831_lab.xml EX-101.LAB 729570
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20200831_pre.xml EX-101.PRE 386259
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-1 | Act: 33 | File No.: 333-250326 | Film No.: 201330355
SIC: 2834 Pharmaceutical Preparations